SC 13G/A | 2023-02-14 | Deep Track Capital, LP | Global Blood Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-09 | FMR LLC | Global Blood Therapeutics, Inc. | 278,419 | 0.4% | EDGAR |
SC 13G | 2022-06-17 | Deep Track Capital, LP | Global Blood Therapeutics, Inc. | 3,646,690 | 5.6% | EDGAR |
SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Global Blood Therapeutics, Inc. | 3,260,685 | 5.0% | EDGAR |
SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Global Blood Therapeutics, Inc. | 183,471 | 0.3% | EDGAR |
SC 13G/A | 2022-02-14 | PERCEPTIVE ADVISORS LLC | Global Blood Therapeutics, Inc. | 3,449,915 | 5.4% | EDGAR |
SC 13G | 2022-02-14 | BAKER BROS. ADVISORS LP | Global Blood Therapeutics, Inc. | 3,314,765 | 5.1% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Global Blood Therapeutics, Inc. | 5,993,142 | 9.3% | EDGAR |
SC 13G/A | 2022-02-10 | JANUS HENDERSON GROUP PLC | Global Blood Therapeutics, Inc. | 5,483,164 | 8.5% | EDGAR |
SC 13G | 2022-02-09 | FMR LLC | Global Blood Therapeutics, Inc. | 4,597,391 | 7.1% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | Global Blood Therapeutics, Inc. | 5,353,056 | 8.3% | EDGAR |
SC 13G/A | 2022-01-31 | BANK OF AMERICA CORP /DE/ | Global Blood Therapeutics, Inc. | 1,603,685 | 2.5% | EDGAR |
SC 13G/A | 2021-10-12 | JANUS HENDERSON GROUP PLC | Global Blood Therapeutics, Inc. | 6,272,682 | 10.1% | EDGAR |
SC 13G | 2021-05-13 | Point72 Asset Management, L.P. | Global Blood Therapeutics, Inc. | 3,086,269 | 5.0% | EDGAR |
SC 13G/A | 2021-05-10 | FMR LLC | Global Blood Therapeutics, Inc. | 1,226,838 | 2.0% | EDGAR |
SC 13G/A | 2021-02-16 | PRICE T ROWE ASSOCIATES INC /MD/ | Global Blood Therapeutics, Inc. | 4,063,123 | 6.5% | EDGAR |
SC 13G/A | 2021-02-16 | PERCEPTIVE ADVISORS LLC | Global Blood Therapeutics, Inc. | 5,674,711 | 9.2% | EDGAR |
SC 13G | 2021-02-12 | JANUS HENDERSON GROUP PLC | Global Blood Therapeutics, Inc. | 5,966,862 | 9.7% | EDGAR |
SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | Global Blood Therapeutics, Inc. | 5,460,482 | 8.8% | EDGAR |
SC 13G/A | 2021-02-08 | FMR LLC | Global Blood Therapeutics, Inc. | 4,407,065 | 7.1% | EDGAR |